Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2

Yingfeng Tu, Lei Jiang, Zhen Cheng and Baozhong Shen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1370;
Yingfeng Tu
1Molecular Imaging Center, The Fourth Hospital of Harbin Medical University, Harbin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Jiang
2Molecular Imaging Program at Stanford, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhen Cheng
2Molecular Imaging Program at Stanford, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baozhong Shen
1Molecular Imaging Center, The Fourth Hospital of Harbin Medical University, Harbin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1370

Objectives Recent studies reported that miR-497 exhibited inhibitory effects in a variety of cancers. However, whether miR-497 is involved in inhibiting angiogenesis, which is critical for tumor growth and metastasis, is still unknown. Hence, the purpose of this study was to investigate the potential role of miR-497 in tumor angiogenesis in breast cancer.

Methods Proliferation and apoptosis analyses were conducted to explore the potential function of miR-497 in human umbilical vein endothelial cells (HUVECs) by using MTT and TUNEL assays. Western blotting (WB) analysis was employed to validate the downstream targets of miR-497 that influence endothelial cells survival and proliferation. Furthermore, in order to disclose the relationship between miR-497 and tumor angiogenesis, VEGFR2-luc transgenic mice were treated with miR-497 mimic and applied to monitor angiogenesis and tumor growth in vivo by using bioluminescent imaging (BLI). Finally, cancer tissues of miR-497 mimic treatment and control groups were employed to analyze the correlation between miR-497 levels and tumor angiogenesis through WB and immunohistochemistry analysis.

Results Overexpression of miR-497 demonstrated inhibitory effects on VEGFR2 activation and downstream Raf/MEK/ERK signal transduction pathways in both HUVECs and tumor tissues. Moreover, overexpression of miR-497 effectively induced endothelial cells apoptosis by targeting VEGFR2 and downstream PI3K/AKT signaling pathway. Furthermore, miR-497 exhibited anti-angiogenesis and anti-tumor effects in the VEGFR2-luc breast tumor model proven by in vivo BLI, in vitro WB and immunohistochemistry analysis.

Conclusions miR-497 inhibits tumor angiogenesis and tumor growth via targeting VEGFR2 in vitro and in vivo, indicating miR-497 can be explored as a potential drug candidate for cancer therapy.

Research Support This work was supported, in part, by the National Natural Science Foundation of China (31210103913), National Natural Science Foundation of China (81130028), Key Grant Project of Heilongjiang Province (GA12C302), and the Office of Science (BER), U.S. Department of Energy (DE-SC0008397).

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
Yingfeng Tu, Lei Jiang, Zhen Cheng, Baozhong Shen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1370;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
Yingfeng Tu, Lei Jiang, Zhen Cheng, Baozhong Shen
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1370;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Generation and validation of a surrogate truth model for xSPECT Bone concordance analysis
  • Investigation of volume-of-interest (VOI) definition methods for estimating organ activity concentrations in quantitative SPECT (QSPECT)
  • SUVmax of Normal Tissues in Pediatric and Adult Patients on FDG PET/MR
Show more Oncology: Basic, Translational & Therapy

MTA I: Oncology Basic, Basic Science Posters

  • Pharmacokinetics and anti-tumor activity of AY002 with high affinity to EGFR-TK
  • The acute effect on three-dimensional cellular proliferation rate of low dose irradiation exposures
  • Detection of tumor cell apoptosis by PET: Comparison of [18F]C-SNAT, [99mTc]HYNIC-Annexin V and [18F]ML-10
Show more MTA I: Oncology Basic, Basic Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire